openPR Logo
Press release

Radiopharmaceuticals Market Estimated to Flourish by 2026

10-27-2017 07:43 AM CET | Health & Medicine

Press release from: Future Market Insights

Radiopharmaceuticals Market Estimated to Flourish by 2026

Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues.

Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals.

In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached an estimated US$ 4,800 million value, and are anticipated to close in on US$ 8,500 million by the end of 2026. In terms of revenue, the global radiopharmaceuticals market is projected to soar steadily at 5.9% CAGR.

View Full Report TOC, Figures and Tables @ https://www.futuremarketinsights.com/reports/radiopharmaceuticals-market

Future Market Insights predicts that shorter half-life of radiopharmaceuticals, and lack of specified guidelines for their use in commercial-scale drug production will restrict the market from growing at higher rate. In the years to come, ageing research reactors from all corners of the world will be closed, which will significantly bring down global production of radiopharmaceuticals. With respect to sourcing these radiopharmaceuticals, the report predicts that nuclear reactors have accounted for more than 60% of global market revenues till date. Shutting down these reactors, however, has propelled the installation of cyclotrons, which are also a feasible source for radioisotopes. Hence, sales of radiopharmaceuticals derived from cyclotrons will continue to increase, amassing more than US$ 6,500 million by the end of 2026.

Surging Demand for Technetium-99 Radioisotope

Production of radiopharmaceuticals can be classified into several key radioisotopes, the prominent ones include, fluorine-18, leutetium-177, gallium-68, gallium-67 and technetium-99. In 2016, sales of radiopharmaceuticals constituting technetium-99 amassed revenues worth over US$ 2,200 million, globally. By the end of 2026, fluorine-18 radioisotope will continue to account for 16% of global radiopharmaceuticals revenues. On the other hand, global radiopharmaceutical revenues accounted by leutetium-177, gallium-68 and gallium-67, respectively, will soar at more than 6% CAGR through 2026.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1992

North America – Dominant Region for Sales of Radiopharmaceuticals

Access to advanced medical facilities, highly-trained professionals and lucrative healthcare expenditure adds up to make North America the most dominant region in global radiopharmaceuticals market. North America’s radiopharmaceuticals revenues will grow at more than 6% CAGR, accounting for nearly 50% of global revenues by the end of 2026. Companies such as Positron Corporation, GE Healthcare, Mallinckrodt plc, Lantheus Holdings, Inc., and Nordion, Inc., are observed to be leading players in global radiopharmaceuticals market, and are all based across North America.

Siemens Healthineers is slated to remain the most dominant company in the global radiopharmaceuticals market, accounting for over 40% of global revenues. Due to participation of Siemens and companies such as Advanced Accelerator Applications (France), Bayer AG (Germany), IBA Radiopharma Solutions (Belgium) and Eckert & Zeigler (Germany), Western Europe’s radiopharmaceuticals market is also expected to expand progressively and close in on US$ 1,600 million valuation by the end of 2026.

Need more information about Report methodology ? https://www.futuremarketinsights.com/askus/rep-gb-1992

Radiopharmaceuticals – Scope for Application & End-use

Favourable growth opportunities for radiopharmaceutical manufacturers from around the world are sited in therapeutic applications such as oncology, cardiology, neuroendocrinology, and neurology, among others.

In 2017 and beyond, consumption of radiopharmaceuticals for oncological procedures will gain traction, registering revenue growth at 6% CAGR.

On the other hand, radiopharmaceuticals consumed by neurological studies & treatment procedures will surge at the highest rate, surpassing US$ 700 million valuation by 2026-end.

Another key insight offered in the report suggests that radiopharmaceuticals used by diagnostic imaging centres will increase over the forecast period.

Buy Full Radiopharmaceuticals Market Report @ https://www.futuremarketinsights.com/checkout/1992

Nevertheless, every second radiopharmaceutical product manufactured in the world will be used by hospitals.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market Estimated to Flourish by 2026 here

News-ID: 789009 • Views: 298

More Releases from Future Market Insights

Hormone Replacement Therapy Market COVID-19 Impact and Global Analysis by Produc …
Hormone Replacement Therapy is any form of hormone therapy where in the patient, in course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. Menopause, is the time in most women's lives when menstrual periods stop permanently, and the woman is no longer able to have children. Menopause typically occurs between 45 and 55 years of age.
Critical Care Information Systems Market Key Players- Affiliated Computer Servic …
Critical care information systems are used to help manage the large amount of data generated in an intensive care unit every day. Obtaining, synchronizing, assimilating, and evaluating patient data is very difficult because of incompatibilities among monitoring equipment, the absence of standard data formatting and proprietary limitations from industry. The intensive care units are a specialized section of a hospital containing the equipment, medical and nursing staff, monitoring and life
Paper Cores Demand Catalyzes amid High Emphasis on Circular Economy: FMI Study
The global packaging industry has made remarkable progress in recent years, with numerous innovations and technological advances prioritized. Particular emphasis is placed on ensuring sustainability and the spread of the circular economy. Reliable benefits have been obtained in reducing the generation of municipal solid waste. Future Market Insights is a recently published research report that incorporates historical analysis from 2015 to 2019 and future assessments from 2020 to 2030 to
Endometrial Cancer Treatment Market Key Players- R-Pharm-US LLC., Bristol-Myers …
Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of women are diagnosed with the endometrial cancer at some point in their lives. According to National Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in the selection of proper treatment options.

All 5 Releases


More Releases for Radiopharma

Global Radiosynthesis Equipment Market by Trends, Dynamic Innovation in Technolo …
The Radiosynthesis Equipment Market report includes overview, which interprets value chain structure, industrial environment, regional analysis, applications, market size, and forecast. The report provides an overall analysis of the market based on types, applications, regions, and for the forecast period from 2020 to 2026. It also offers investment opportunities and probable threats in the market based on an intelligent analysis. This report focuses on the Global Radiosynthesis Equipment Market trends, future
Automated Radiosynthesis Modules Market 2019 | Global Forecast 2025 | Top Key Pl …
As per the latest research study published by Up Market Research, “Global Automated Radiosynthesis Modules Market” is estimated to grow at a healthy CAGR % in the coming years. The research report showcases qualitative and quantitative estimations by the industry analysts. The report documents first-hand data, post verification from the industry experts along with each industry manufacturers by the market valuation. Automated Radiosynthesis Modules Market report also gives an extensive
Global Radiopharmaceutical Market 2019 Advancements – Advanced Accelerator App …
Researchmoz added Most up-to-date research on "Radiopharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024" to its huge collection of research reports. This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development of new sources for radioisotope production, and rise in demand for nuclear medicine are boosting the radiopharmaceutical market. Increase in
Radiopharmaceuticals Market to 2016-2026: Advanced Accelerator Applications (Fra …
Researchmoz added Most up-to-date research on "Radiopharmaceuticals Market: Will Japan (Expected to Register an Attractive Growth Rate Throughout the Forecast Period) Beat Current Market Leader North America? - Global Industry Analysis and Opportunity Assessment, 2016-2026" to its huge collection of research reports. North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals market North America accounted for more than 40% market share in the global radiopharmaceuticals market
Radiopharmaceuticals Market Competitive Scenario of Leading Key Players 2016 and …
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1992 In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached
Automated Radiosynthesis Modules Market – Product Diversification 2025 | IBA R …
Global Automated Radiosynthesis Modules Market: Snapshot The global automated radiosynthesis modules market is forecasted to be a million-dollar opportunity for industry participants expected to be encouraged by a colossal demand in the recent years. End users of automated radiosynthesis modules could ensure an improved performance in their therapy monitoring and diagnostic activities. With the help of these modules, end users could also gain a wide scope for the customization of radiotracers.